Sino Biopharm Stock - Weekly review and peer comparison in China pharma
19.06.2026 - 20:38:44 | ad-hoc-news.de
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 20:36 CET. Details in the imprint.
Sino Biopharm (KYG8087W1029) remains without fresh market-moving news this week. In the absence of a new earnings release or regulatory filing, attention shifts to how the Chinese drug maker’s stock compares with peers in Hong Kong’s health care segment.
All news and data on Sino Biopharm stock
Key filings, price data and past earnings reports on Sino Biopharm can be found in the dedicated topic area and on the company’s investor relations page.
How the week shaped up
There were no new earnings reports, capital measures or major regulatory announcements from Sino Biopharmaceutical Ltd. in the past few days, based on checks of the company’s investor relations page and Hong Kong stock exchange disclosures.
Sector news in China’s pharmaceutical industry centered instead on other players, including updates on new drug approvals and fundraising by biotech peers, underscoring a broadly active but selective market environment.
Position versus peers this week
Sino Biopharm is part of a wider group of Chinese health care and biotech stocks in Hong Kong that has faced mixed investor sentiment this year, as policy signals and pricing reforms continue to shape expectations for earnings quality.
Against this backdrop, investors often compare Sino Biopharm with other large Chinese drug makers listed in Hong Kong when assessing relative exposure to prescription drugs, innovative therapies and government reimbursement programs.
How the company makes money
Sino Biopharm generates most of its revenue from the research, development, manufacturing and sale of pharmaceutical products in China, with a focus on therapeutics for oncology, cardiovascular, hepatitis and other chronic diseases.
Where the stock trades today
The shares of Sino Biopharm (KYG8087W1029) trade on the Hong Kong Stock Exchange; the latest verified quote was available in Hong Kong dollars on the regular trading venue.
Key facts on Sino Biopharm stock
- Company: Sino Biopharmaceutical Ltd.
- ISIN: KYG8087W1029
- WKN: 813 86M
- Ticker: 1177
- Venue: HKEX
- Sector / Industry: Health Care / Pharmaceuticals
- Index membership: Hang Seng Composite Index (health care segment)
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
